ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Eledon Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.16+0.03 (+1.41%)
Close on Oct 19, 2026
- Market cap
- $245.44M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.28 (−37.21%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $245.44M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 7.43
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$98.56M
- EPS, diluted
- -$0.91
- Book value per share
- $0.29
- Diluted shares
- 114M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
–
Net income
-$98.56M-773.1% YoY
EPS, diluted
-$0.91
Free cash flow
–
Reported periodTrailing twelve months